Enhancing Clinical Trials: How SitePlus Revolutionizes Patient Recruitment and Retention

Introduction to SitePlus

SitePlus is an innovative solution designed to optimize clinical trials by improving patient recruitment and retention. This platform is the result of a successful collaboration between United BioSource LLC (UBC) and Thread. The expansion of SitePlus, launched in March 2023, has shown remarkable results in early recruitment and retention efforts for biopharma sponsors.

Central Site Model

The central site model offered by SitePlus extends the reach of clinical sites and widens the population of patients who can participate in studies. This model is not restricted by geographic barriers, allowing for a larger and more diverse patient pool. Additionally, the use of a centralized technology platform helps accelerate patient recruitment and improve overall patient retention.

Features and Enhancements

SitePlus combines UBC's late-stage research solutions with Thread's technology. This powerful duo enhances central site study designs focused on patient-centric approaches. The integrated platform includes features such as home health engagement, secure data capture, and virtual visits to facilitate patient participation and improve the research experience for all involved.

Benefits for Biopharma Sponsors

Biopharma sponsors benefit from SitePlus by having access to a centralized research center complete with investigator and study coordinating center concierge support services. This integration simplifies the contracting process and streamlines study coordination, ultimately leading to better patient outcomes and more reliable data for decision-making.

Home Health Engagement

The inclusion of home health engagement in SitePlus allows patients to participate in clinical trials from the comfort of their own homes. This feature is particularly beneficial for patients who may have mobility issues or are unable to travel frequently. Home health visits ensure that patients receive consistent care and support throughout the trial.

Data Security and Privacy

SitePlus prioritizes data security and privacy, ensuring that all patient information is securely captured and stored. The platform complies with stringent regulatory standards, giving both patients and sponsors confidence in the integrity of the data collected.

Virtual Visits and Patient Retention

Virtual visits are a key feature of SitePlus, enabling patients to engage with study coordinators and healthcare professionals without the need to be physically present at the clinical site. This flexibility helps maintain patient engagement and retention, reducing the likelihood of dropout rates during the study.

Customized Study Designs

SitePlus supports both interventional and post-approval research studies, offering customized study designs tailored to meet the specific needs and goals of each trial. This adaptability makes it a valuable tool for a wide range of clinical research endeavors.

Success Stories

Studies utilizing the SitePlus platform have reported significant improvements in reaching more representative patient populations and maintaining engagement. The hybrid approach of combining traditional site models with modern technology has proven effective in accelerating the recruitment process and enhancing patient retention.

Future Prospects

The ongoing collaboration between UBC and Thread aims to further expand the capabilities of SitePlus, incorporating additional features and services to continue driving innovation in clinical trials. The feedback from biopharma sponsors and the success of early implementations indicate a promising future for this joint solution.